COMP <GO>
RNXT vs HRTX // OPERATING MARGIN
RenovoRx Inc. (NASDAQ) VS. Heron Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: RNXT 2
— HRTX 4
▲ OPERATING MARGIN LEADER: HRTX
LAST: $1.29 (+2.38%) • MKT CAP: $56.9M
operating-margins
-60.00%
LAST: $0.28 (-3.52%) • MKT CAP: $56.0M
operating-margins
-1.60%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RNXT VS. HRTX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | RNXT | HRTX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 70.90% | 73.30% | -2.40 | HRTX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -16.32% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin ACTIVE | -60.00% | -1.60% | -58.40 | HRTX | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -12.90% | -47.10 | HRTX | /net-margins <GO> |
| Revenue Growth (YoY) | 180.00% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.40 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 2/9 | +2.00 | RNXT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 43.0 | 43.7 | -0.70 | HRTX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $56.9M | $56.0M | $837.8K | RNXT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | RNXT REV | HRTX REV | RNXT GROSS % | HRTX GROSS % | RNXT FCF | HRTX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.1M | $154.9M | 70.9% | 73.3% | -$11.0M | -$27.9M |
| FY 2024 | $43.0K | $144.3M | 98.0% | 73.2% | -$9.1M | -$24.2M |
| FY 2023 | $31.9M | $309.7M | — | — | -$10.3M | -$58.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RNXT // BETA —
HRTX // BETA —